Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.03.2022 | Case report

Daptomycin/linezolid

Acquired resistance: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Al-Heeti O, et al. Development of Linezolid and Daptomycin Resistance in Vancomycin Resistant Enterococcus faecium (VRE) during prolonged treatment for Intraabdominal Abscess. Open Forum Infectious Diseases 8 (Suppl. 1): S714 (plus poster) abstr. 1250, Nov 2021. Available from: URL: http://doi.org/10.1093/ofid/ofab466.1442 [abstract] Al-Heeti O, et al. Development of Linezolid and Daptomycin Resistance in Vancomycin Resistant Enterococcus faecium (VRE) during prolonged treatment for Intraabdominal Abscess. Open Forum Infectious Diseases 8 (Suppl. 1): S714 (plus poster) abstr. 1250, Nov 2021. Available from: URL: http://​doi.​org/​10.​1093/​ofid/​ofab466.​1442 [abstract]
Metadaten
Titel
Daptomycin/linezolid
Acquired resistance: case report
Publikationsdatum
01.03.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-12130-2

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Pembrolizumab

Case report

Imatinib

Case report

Naproxen

Case report

Alitretinoin